Company: JACS-RI
Filing Date: 2025-03-18
Form Type: 10-K
Source: 0001013762-25-000620
Chunk: 874

Company: Jackson Acquisition Co II
Filing Date: 2025-03-18
Form: 10-K
Item: Item 8
Chunk 874
---
ash Investing and Financing Activities: 

    Offering costs included in accrued offering costs 
    $155,484 
  
    Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 
    $25,000 
  
    Deferred offering costs paid through promissory note – related party 
    $137,604 
  
    Offering costs paid to prepaid expense 
    $14,099 
  
    Offering costs charged to Additional paid in capital 
    $557,741 
  
    Accretion of Class A ordinary shares to redemption value 
    $10,694,910 

The accompanying notes are an integral
part of these financial statements.

F-6

JACKSON
ACQUISITION COMPANY II 
NOTES TO FINANCIAL STATEMENTS

NOTE
1 — ORGANIZATION AND PLAN OF BUSINESS OPERATIONS

Jackson Acquisition Company II (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on September 11, 2024. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses (“Business Combination”).

While the Company may pursue an initial business
combination target in any industry or geographic location, the Company intends to focus its search for a target business by concentrating
its efforts in identifying high-quality businesses with a focus on healthcare services, healthcare technology, or otherwise focused on
the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the
risks associated with early stage and emerging growth companies.

As of December 31, 2024, the Company had not commenced
any operations. All activity for the period from September 11, 2024 (inception) through December 31, 2024, relates to the Company’s
formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31
as its fiscal year end.

 The registration statement for the Company’s
Initial Public Offering was declared effective on December 9, 2024. On December 11, 2024, the Company consumm